Table 2.
Cmax and Tmax for plasma DHA, EPA and EPA + DHA by treatment
| Soup | Extruded rice snack | Gel capsule | P valuea | ||||
|---|---|---|---|---|---|---|---|
| Mean | 95% CI | Mean | 95% CI | Mean | 95% CI | ||
| DHA Cmax (µg/mL) | 52.4 | [50.0, 54.9] | 51.5 | [49.1, 54.0] | 55.2 | [52.8, 57.6] | 0.06 |
| EPA Cmax (µg/mL) | 18.5 | [17.9, 19.1] | 18.4 | [17.8, 19.0] | 18.6 | [18.0, 19.2] | 0.86 |
| DHA + EPA Cmax (µg/mL) | 70.5 | [67.7, 73.3] | 69.6 | [66.8, 72.4] | 73.5 | [70.6, 76.3] | 0.12 |
| Median | 25, 75 Percentile | Median | 25, 75 Percentile | Median | 25, 75 Percentile | P valueb | |
|---|---|---|---|---|---|---|---|
| DHA Tmax (hours) | 4 | [2, 8] | 4 | [2, 6] | 6 | [4, 6] | 0.12 |
| EPA Tmax (hours) | 6 | [2, 8] | 6 | [2, 8] | 6 | [4, 8] | 0.50 |
| DHA + EPA Tmax (hours) | 4 | [4, 8] | 4 | [2, 6] | 6 | [4, 6] | 0.50 |
DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; Cmax, maximal concentration; Tmax, time to maximal concentration
aComparisons between treatments were performed using linear mixed effects models (n = 27) including treatment as fixed effect while controlling for ethnic and Time0 for the respective variable and treatment. Treatment*ethnicity and treatment*allocation order were not significant (P > 0.05)
bComparisons between treatments were performed using the non-parametric Friedman Test for related samples